Background: The risk of atrial fibrillation recurrences (AFR) after cardioversion(CV) is one of the most important problems in the treatment of this arrhythmia. Literature data showed that amiodarone is the most effective antiarrhythmic drug in sinus rhythm maintenance.Several studies have recently demonstrated that also non-antiarrhythmic drugs as RAS inhibitors (RASi) and n-3 PUFAs can prevent atrial remodeling and reduce AF occurrence or recurrences. At present only few evidences suggested the beneficial effect of n-3PUFAS in AF. This study has evaluated the role of n-3 PUFAs in addition to amiodarone and RASi on maintaining sinus rhythm (SR) after conversion from persistent AF.
